Baron JA. Epidemiology of non-steroidal anti-inflammatory drugs and cancer [J]. Prog Exp Tumor Re, 2003, 37(1): 1-24.
[3]
Cerdan FJ, Torresmelero J, Martinez S, et al. Treatment of familiar adenomatous polyposis-coli with sulindac[J]. Revista Espanola De Enfermedades Digestivas, 1995, 87(8): 574-576.
[4]
Cruzcorrea M, Hylind LM, Romans KE, et al. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study[J]. Gastroenterology, 2002, 122(3): 641-645.
[5]
Hixson LJ, Earnest DL, Fennerty MB, et al. NSAID effect on sporadic colon polyps[J]. Am J Gastroenterol, 1993, 88(10): 1652-1656.
[6]
Niv Y, Fraser GM. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy[J]. Gastroenterology, 1994, 107(3): 854-857.
[7]
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5. 0. 1 [updated September 2008]. The Cochrane Collaboration, 2008.
[8]
Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis[J]. N Engl J Med, 1993, 328(18): 1313-1316.
[9]
Nugent KP, Farmer KC, Spigelman AD, et al. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis[J]. Br J Surg, 1993, 80(12): 1618-1619.
[10]
Giardiello FM, Yang VW, Hylind LM, et al. Primary chemoprevention of familial adenomatous polyposis with sulindac[J]. N Engl J Med, 2002, 346(14): 1054-1059.
[11]
Ladenheim J, Garcia G, Titzer D, et al. Effect of sulindac on sporadic colonic polyps[J]. Gastroenterology, 1995, 108(4): 1083-1087.
